2m 2m 2m 2m 2m 2m 2m
KEROS THERAP (KROS)
NASDAQ
$9.53-$0.010 (-0.10%)
Price as of Nov 12, 2026 10:02 AM EST- $187.2MMarket Cap
- -45.39%1-Year Change
- BiotechnologyIndustry
KEROS THERAP (KROS)
$9.53-$0.010 (-0.10%)
KROS | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $9.54 | ||
Change | +$0.21 (+2.25%) | ||
Open | $9.37 | ||
High | $9.72 | ||
Low | $9.16 | ||
Previous Close | $9.33 | ||
Volume | 221,664 | ||
30-Day Average Volume | 164,628 | ||
1-Week Change | -11.91% | ||
1-Month Change | -20.17% | ||
1-Year Change | -45.39% | ||
3-Year Change | -67.74% | ||
5-Year Change | -83.92% | ||
Fundamentals | |||
Shares Outstanding | 19.6M | ||
Total Assets | $307.4M | ||
Market Cap | $187.2M | ||
Enterprise Value | -$72.2M | ||
Period: QTR TTM FY | |||
Revenue | $20.0M | ||
Net Income | $14.2M | ||
Free Cash Flow | $3.3M | ||
EBIT | $14.9M | ||
EBITDA | $15.3M | ||
Net Working Capital | $271.8M | ||
EPS | $0.70 | ||
Enterprise Value/EBITDA | -5 | ||
Enterprise Value/Revenue | -4 | ||
P/B | 1 | ||
P/E | 14 | ||
PEG | 0 | ||
Price/Free Cash Flow | 56 | ||
Price/Operating Cash Flow | 55 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue